MDGL vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

MDGL

52.4
AI Score
VS
BBIO Wins

BBIO

55.7
AI Score

Investment Advisor Scores

MDGL

52score
Recommendation
HOLD

BBIO

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDGL BBIO Winner
Revenue 194.51M 675.59M MDGL
Net Income -166.56M -152.33M MDGL
Net Margin -85.6% -22.5% MDGL
Operating Income -105.96M -149.03M BBIO
ROE 7.3% -29.1% BBIO
ROA -12.1% -12.2% BBIO
Total Assets 1.37B 1.24B BBIO
Cash 879.89M 292.73M BBIO
Debt/Equity -1.16 0.65 BBIO
Current Ratio 1.52 3.20 MDGL
Free Cash Flow -197.35M -152.21M MDGL

Relative Price Performance (Last 90 Days)

MDGL 1M: -9.2% · 3M: -9.7% BBIO 1M: +7.5% · 3M: +12.6%

Current Technical Phase

MDGL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 32.9 · Price: $467.32

BBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.8% over 20 days), RSI 51

RSI (14): 50.8 · Price: $80.09

Fundamentals Snapshot

Metric MDGL BBIO
Market Cap
Forward P/E 39.8 140.8
Trailing P/E
Revenue (TTM)
Revenue Growth 1.3% 0.7%
Gross Margin 0.9% 1.0%
Operating Margin -0.3% -0.5%
EPS -13.73 -3.67
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBIO is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.